| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silo Pharma, Inc. | Director | Options (right to buy) | 53,425 | 23 May 2025 | Direct | ||
| Hoth Therapeutics, Inc. | Director | Options | 25,000 | 19 Aug 2024 | Direct | ||
| Myseum, Inc. | Director | Options (right to buy) | 5,000 | 18 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MYSE | Myseum, Inc. | 18 Aug 2025 | 1 | $0 | 4 | Director | 19 Aug 2025, 16:31 |
| SILO | Silo Pharma, Inc. | 23 May 2025 | 1 | $0 | 4 | Director | 27 May 2025, 19:03 |
| DATS | DatChat, Inc. | 14 Jan 2025 | 1 | $0 | 4 | Director | 16 Jan 2025, 17:00 |
| HOTH | Hoth Therapeutics, Inc. | 19 Aug 2024 | 1 | $0 | 4 | Director | 21 Aug 2024, 16:15 |
| HOTH | Hoth Therapeutics, Inc. | 05 Jan 2024 | 1 | $0 | 4 | Director | 08 Jan 2024, 17:01 |
| HOTH | Hoth Therapeutics, Inc. | 17 Jul 2023 | 1 | $0 | 4 | Director | 18 Jul 2023, 16:15 |
| HOTH | Hoth Therapeutics, Inc. | 16 Mar 2022 | 1 | $0 | 4 | Director | 18 Mar 2022, 16:15 |
| SILO | Silo Pharma, Inc. | 29 Dec 2021 | 1 | $0 | 4/A | Director | 05 Jan 2022, 17:18 |
| DATS | DatChat, Inc. | 28 Sep 2021 | 1 | $0 | 4 | Director | 30 Sep 2021, 16:33 |
| DATS | DatChat, Inc. | 17 Aug 2021 | 1 | $0 | 4 | Director | 20 Aug 2021, 10:31 |
| DATS | DatChat, Inc. | 13 Aug 2021 | 1 | $0 | 4/A | Director | 12 Oct 2021, 17:16 |
| DATS | DatChat, Inc. | 12 Aug 2021 | 0 | $0 | 3 | Director | 13 Aug 2021, 19:33 |